Global Blood Therapeutics (GBT), (PFHD) – NOTICE TO SHAREHOLDERS: Halper…

Global Blood Therapeutics (GBT), (PFHD) – NOTICE TO SHAREHOLDERS: Halper…

Facebook
Twitter
LinkedIn

NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for possible violations of federal securities laws and/or violations of shareholder fiduciary duties related to:

Global Blood Therapeutics, Inc. GBT‘s Sold to Pfizer Inc. for $68.50 per share in cash. If you are a Global Blood shareholder, Click here to learn more about your rights and options.

Professional Holding Corp. PFHD‘s Sold to Seacoast Banking Corporation of Florida for 0.8909 common shares of Seacoast for each Professional common share. If you are a professional shareholder, Click here to learn more about your rights and options.

Shareholders are encouraged to contact the company for free to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors worldwide who have been victims of securities fraud and corporate wrongdoing. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

lawyer advertising. Previous results do not guarantee a similar result.

Contact information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com


[ad_2]

Source story

More to explorer